Cyclophosphamide Therapy for Corticoresistant Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome in a Patient With Severe Kidney and Eye Involvement and Epstein-Barr Virus Reactivation
Emilie Laban(Centre Hospitalier Universitaire de Poitiers), Frank Bridoux(Université de Poitiers), E. Sztermer(Centre Hospitalier Universitaire de Poitiers), François Pourreau(Centre Hospitalier Universitaire de Poitiers), G. Guillet(Centre Hospitalier Universitaire de Poitiers), E. Hainaut-Wierzbicka(Centre Hospitalier Universitaire de Poitiers), Mokrane Yacoub(Centre Hospitalier Universitaire de Bordeaux), Guy Touchard(Centre Hospitalier Universitaire de Poitiers)
Cited by 47
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520